Hand-Eczema Burden in a 20,000-Person Gothenburg Survey
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What can this study tell workers, families and occupational-health teams—and what would go beyond the evidence? This review keeps every number attached to its population, denominator, comparator and timepoint.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 20,000 Gothenburg residents aged 20-65 sampled from the population register; 83% responded and 1,385 people reporting 12-month hand eczema attended examination. |
| Design | Population questionnaire with dermatologic examination and patch testing of symptom-positive respondents plus dropout analysis. |
| Comparator | Sex, occupation, exposure and diagnostic subtypes within the population and examined subgroup. |
| Timepoint | Twelve-month period prevalence and point prevalence, with work change and historical sick-leave questions. |
| Key result | Estimated 12-month prevalence was about 11% and point prevalence 5.4%. Among examined cases, 21% reported at least one eczema-related sick leave and 8% reported changing work primarily because of hand eczema. |
| Funding/conflict context | No funding or conflict statement appears in the PubMed abstract. |
What was actually measured?
Estimated 12-month prevalence was about 11% and point prevalence 5.4%. Among examined cases, 21% reported at least one eczema-related sick leave and 8% reported changing work primarily because of hand eczema.
The large random population frame and examination step are strengths. The work findings show functional burden, but they are historical associations rather than proof that a specific workplace caused each case.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
The study is older, relies partly on recall, and examined only people who self-identified 12-month symptoms; occupation and exposure patterns have changed since the survey.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 2145721
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Industrial Dermatitis Across 369 Singapore Notifications
- Cold and SLS Exposure in 20 and 12 Healthy Volunteers
- Chemical-Glove Selection and Use Reported by 817 Japanese Workers
- Interpreting Hand-Eczema Severity Change in 294 Patients
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.